Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice

Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α

Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · see citing works

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

Hoff, D. D. V., LAYARD, M. W., BASA, P., DAVIS, H. L., HOFF, A. L. V., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,388 · see citing works

Untitled work

O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173 · see citing works

Canadian Cancer Statistics 2012

Gaudette, L. A., Illing, E. M., & Hill, G. B. (2012) · PsycEXTRA Dataset · doi:10.1037/e611042012-001 · Cited by 1,507 · see citing works

Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

Courneya, K. S., SEGAL, R. J., Mackey, J. R., Gelmon, K. A., Reid, R. D., Friedenreich, C. M., Ladha, A. B., Proulx, C., Vallance, J. K., Lane, K. N., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2024 · Cited by 1,182 · see citing works

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

Tan-Chiu, E., Yothers, G., Romond, E. H., Geyer, C. E., Ewer, M. S., Keefe, D. L., Shannon, R. P., Swain, S. M., Brown, A. M., Fehrenbacher, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4091 · Cited by 801 · see citing works

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 770 · see citing works

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Swain, S. M., Whaley, F. S., Gerber, M. C., Weisberg, S. P., York, M., Spicer, D. V., Jones, S. E., Wadler, S., Desai, A. V., Vogel, C. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1318 · Cited by 661 · see citing works

Natural history of asymptomatic left ventricular systolic dysfunction in the community

Wang, T. J., Evans, J. C., Benjamin, E. J., Levy, D., LeRoy, E. C., & Vasan, R. S. (2003) · Circulation · doi:10.1161/01.cir.0000085166.44904.79 · Cited by 633 · see citing works

The anthracyclines: will we ever find a better doxorubicin?

Weiss, R. B. (1992) · PubMed · Cited by 558 · see citing works

Cardioprotective interventions for cancer patients receiving anthracyclines

van Dalen, E. C., Caron, H. N., Dickinson, H. O., & Kremer, L. C. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003917.pub4 · Cited by 553 · see citing works

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

Perez, E. A., Suman, V. J., Davidson, N. E., Sledge, G. W., Kaufman, P. A., Hudis, C. A., Martino, S., Gralow, J. R., Dakhil, S. R., Ingle, J. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5467 · Cited by 537 · see citing works

A Meta-Analysis of the Effect of Exercise Training on Left Ventricular Remodeling in Heart Failure Patients

Haykowsky, M. J., Liang, Y., Pechter, D., Jones, L. W., McAlister, F. A., & Clark, A. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.055 · Cited by 396 · see citing works

Modest Increase in Peak VO 2 Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients

Swank, A. M., Horton, J., Fleg, J. L., Fonarow, G. C., Keteyian, S. J., Goldberg, L. R., Wolfel, G., Handberg, E. M., Bensimhon, D., Illiou, M.-C., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.965186 · Cited by 385 · see citing works

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

Ewer, M. S., & Ewer, S. M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.121 · Cited by 375 · see citing works

Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults

Héquet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., Dumontet, C., Thiéblemont, C., Arnaud, P., Antal, D., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.033 · Cited by 338 · see citing works

Chemosensitization of tumors by resveratrol

Gupta, S. C., Kannappan, R., Reuter, S., Kim, J. H., & Aggarwal, B. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05852.x · Cited by 308 · see citing works

Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders

Mattson, M. P. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.07.003 · Cited by 303 · see citing works

Effect of Exercise Training on Peak Oxygen Consumption in Patients with Cancer: A Meta-Analysis

Jones, L. W., Liang, Y., Pituskin, E., Battaglini, C. L., Scott, J. M., Hornsby, W., & Haykowsky, M. J. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0197 · Cited by 280 · see citing works

Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway

Brookins-Danz, E. D., Skramsted, J., Henry, N., Bennett, J. A., & Keller, R. S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.011 · Cited by 266 · see citing works

Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1

Dolinsky, V. W., Chan, A. Y. M., Frayne, I. R., Light, P. E., Rosiers, C. D., & Dyck, J. R. B. (2009) · Circulation · doi:10.1161/circulationaha.108.787440 · Cited by 232 · see citing works

Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods

Whitesall, S. E., Hoff, J., Vollmer, A. P., & D’Alecy, L. G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01089.2003 · Cited by 216 · see citing works

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53

Zhang, C., Feng, Y., Qu, S., Wei, X., Zhu, H., Luo, Q., Liu, M., Chen, G., & Xiao, X. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr022 · Cited by 214 · see citing works

Prospective Evaluation of Early Cardiac Damage Induced by Epirubicin-Containing Adjuvant Chemotherapy and Locoregional Radiotherapy in Breast Cancer Patients

Meinardi, M. T., van Veldhuisen, D. J., Gietema, J. A., Dolsma, W. V., Boomsma, F., van den Berg, M. P., Volkers, C., Haaksma, J., de Vries, E. G. E., Sleijfer, D. T., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2746 · Cited by 206 · see citing works

Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer

Scott, J. M., Khakoo, A. Y., Mackey, J. R., Haykowsky, M. J., Douglas, P. S., & Jones, L. W. (2011) · Circulation · doi:10.1161/circulationaha.111.021774 · Cited by 188 · see citing works

Mitochondrial fusion and division: Regulation and role in cell viability

Bénard, G., & Karbowski, M. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.12.012 · Cited by 182 · see citing works

Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats

Dolinsky, V. W., Jones, K. E., Sidhu, R. S., Haykowsky, M. J., Czubryt, M. P., Gordon, T., & Dyck, J. R. B. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.230490 · Cited by 174 · see citing works

Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure

Thandapilly, S. J., Wojciechowski, P. W., Behbahani, J., Louis, X. L., Yu, L., Juric, D., Kopilas, M. A., Anderson, H. D., & Netticadan, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.228 · Cited by 172 · see citing works

Calorie restriction and resveratrol in cardiovascular health and disease

Dolinsky, V. W., & Dyck, J. R. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.010 · Cited by 168 · see citing works

Exercise-induced cardioprotection — biochemical, morphological and functional evidence in whole tissue and isolated mitochondria

Ascensão, A. A. M. R., Ferreira, R. M., & Magalhães, J. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.076 · Cited by 160 · see citing works

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

Tatlıdede, E., Şehırlı, Ö., Velioğlu‐Öğünç, A., Çetınel, Ş., Yeğen, B. Ç., Yarat, A., Süleymanoğlu, S., & Şener, G. (2009) · Free Radical Research · doi:10.1080/10715760802673008 · Cited by 156 · see citing works

Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity

Chicco, A. J., Hydock, D. S., Schneider, C. M., & Hayward, R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00148.2005 · Cited by 144 · see citing works

Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure

Rimbaud, S., Ruiz, M., Piquereau, J., Matéo, P., Fortin, D., Veksler, V., Garnier, A., & Ventura‐Clapier, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026391 · Cited by 142 · see citing works

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer

Trudeau, M., Charbonneau, F., Gelmon, K. A., Laing, K. E., Latreille, J., Mackey, J. R., McLeod, D., Pritchard, K. I., Provencher, L., & Verma, S. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70424-1 · Cited by 136 · see citing works

Effect of Doxorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients With Breast Cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

Perez, E. A., Suman, V. J., Davidson, N. E., Kaufman, P. A., Martino, S., Dakhil, S. R., Ingle, J. N., Rodeheffer, R. J., Gersh, B. J., & Jaffe, A. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.516 · Cited by 131 · see citing works

Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training

Haykowsky, M. J., Mackey, J. R., Thompson, R. B., Jones, L. W., & Paterson, D. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0628 · Cited by 127 · see citing works

Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress

Gratia, S., Kay, L., Potenza, L., Seffouh, A., Novel-Chaté, V., Schnebelen, C., Sestili, P., Schlattner, U., & Tokarska-Schlattner, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs134 · Cited by 119 · see citing works

Calorie Restriction Prevents Hypertension and Cardiac Hypertrophy in the Spontaneously Hypertensive Rat

Dolinsky, V. W., Morton, J. S., Oka, T., Frayne, I. R., Bagdan, M., Lopaschuk, G. D., Rosiers, C. D., Walsh, K. X., Davidge, S. T., & Dyck, J. R. B. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.154732 · Cited by 119 · see citing works

Early Detection of Doxorubicin Cardiomyopathy Using Two-Dimensional Strain Echocardiography

Migrino, R. Q., Aggarwal, D., Konorev, E. A., Brahmbhatt, T., Bright, M., & Kalyanaraman, B. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.07.018 · Cited by 118 · see citing works

Activation of AMP-Activated Protein Kinase Contributes to Doxorubicin-Induced Cell Death and Apoptosis in Cultured Myocardial H9c2 Cells

Chen, M., Wu, X., Gu, J., Guo, Q.-T., Shen, W., & Lu, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9153-0 · Cited by 117 · see citing works

Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72

Kavazis, A. N., Smuder, A. J., Min, K., Tümer, N., & Powers, S. K. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00585.2010 · Cited by 100 · see citing works

Acute Exercise Protects Against Doxorubicin Cardiotoxicity

Wonders, K. Y., Hydock, D. S., Schneider, C. M., & Hayward, R. (2008) · Integrative Cancer Therapies · doi:10.1177/1534735408322848 · Cited by 98 · see citing works

Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo.

Shadfar, S., Couch, M. E., McKinney, K. A., Weinstein, L. J., Yin, X., Rodríguez, J. E., Guttridge, D. C., & Willis, M. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.563032 · Cited by 98 · see citing works

Transcriptional analysis of doxorubicin-induced cardiotoxicity

Yi, X., Bekeredjian, R., DeFilippis, N. J., Siddiquee, Z., Fernández, E., & Shohet, R. V. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00832.2005 · Cited by 97 · see citing works

Trans- but Not Cis-Resveratrol Impairs Angiotensin-II–Mediated Vascular Inflammation through Inhibition of NF-κB Activation and Peroxisome Proliferator-Activated Receptor-γ Upregulation

Rius, C., Abu-Taha, M. I., Hermenegildo, C., Piqueras, L., Cerdá‐Nicolás, M., Issekutz, A. C., Estañ, L., Cortijo, J., Morcillo, E. J., Orallo, F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001043 · Cited by 96 · see citing works

Persistent Alterations to the Gene Expression Profile of the Heart Subsequent to Chronic Doxorubicin Treatment

Berthiaume, J. M., & Wallace, K. B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0026-0 · Cited by 90 · see citing works

Effects of Exercise Training on Antitumor Efficacy of Doxorubicin in MDA-MB-231 Breast Cancer Xenografts

Jones, L. W., Eves, N. D., Courneya, K. S., Chiu, B., Baracos, V. E., Hanson, J., Johnson, L., & Mackey, J. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0844 · Cited by 86 · see citing works

Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats

Toklu, H. Z., Şehırlı, Ö., Erşahin, M., Süleymanoğlu, S., Yiğiner, Ö., Emekli‐Alturfan, E., Yarat, A., Yeğen, B. Ç., & Şener, G. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01197.x · Cited by 80 · see citing works

Continued Postnatal Administration of Resveratrol Prevents Diet-Induced Metabolic Syndrome in Rat Offspring Born Growth Restricted

Dolinsky, V. W., Rueda‐Clausen, C. F., Morton, J. S., Davidge, S. T., & Dyck, J. R. B. (2011) · Diabetes · doi:10.2337/db11-0374 · Cited by 73 · see citing works

Myocardial sarcoplasmic reticulum Ca2+ATPase function is increased by aerobic interval training

Kemi, O. J., Ceci, M., Condorelli, G., Smith, G. L., & Wisløff, U. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282efd4e0 · Cited by 69 · see citing works

Doxorubicin Cardiac Dysfunction: Effects on Calcium Regulatory Proteins, Sarcoplasmic Reticulum, and Triiodothyronine

Olson, R. D., Gambliel, H. A., Vestal, R. E., Shadle, S. E., Charlier, H. A., & Cusack, B. J. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:3:269 · Cited by 63 · see citing works

Exercise Preconditioning Provides Long-Term Protection Against Early Chronic Doxorubicin Cardiotoxicity

Hydock, D. S., Lien, C., Jensen, B. T., Schneider, C. M., & Hayward, R. (2011) · Integrative Cancer Therapies · doi:10.1177/1534735410392577 · Cited by 58 · see citing works

Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression

Neilan, T. G., Jassal, D. S., Scully, M. F., Chen, G., Deflandre, C., McAllister, H., Kay, E. W., Austin, S. C., Halpern, E. F., Harmey, J. H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl003 · Cited by 33 · see citing works

Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.

Duraj, J., Bodo, J., Sulíková, M., Rauko, P., & Sedlák, J. (2006) · PubMed · Cited by 22 · see citing works

Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology—findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study

Whellan, D. J., Nigam, A., Arnold, M., Starr, A. Z., Hill, J. A., Fletcher, G. F., Ellis, S. J., Cooper, L. S., Onwuanyi, A., Chandler, B., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.09.017 · Cited by 19 · see citing works

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,607 · see citing works

Oxidative stress injury in doxorubicin-induced cardiotoxicity

Mei, S., Hong, L., Xinyong, C., Bin, X., Ping, Z., & Shao, L. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.02.013 · Cited by 571 · see citing works

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases

Zordoky, B. N. M., Robertson, I. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.016 · Cited by 340 · see citing works

The pharmacology of resveratrol in animals and humans

Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302 · see citing works

Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity

Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. T. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.10.003 · Cited by 259 · see citing works

Exercise training in cancer control and treatment

Christensen, J. F., Simonsen, C., & Hojman, P. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180016 · Cited by 203 · see citing works

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Denlinger, C. S., Sanft, T., Baker, K. S., Broderick, G., Demark-Wahnefried, W., Friedman, D. L., Goldman, M., Hudson, M., Khakpour, N., King, A., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0078 · Cited by 199 · see citing works

Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes

Cheung, K. G., Cole, L., Xiang, B., Chen, K., Ma, X., Myal, Y., Hatch, G. M., Tong, Q., & Dolinsky, V. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.607960 · Cited by 175 · see citing works

Weight gain following breast cancer diagnosis: Implication and proposed mechanisms

Makari‐Judson, G. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.272 · Cited by 160 · see citing works

Sexual Dimorphism of Doxorubicin-Mediated Cardiotoxicity

Moulin, M., Piquereau, J., Matéo, P., Fortin, D., Rücker‐Martin, C., Gressette, M., Lefebvre, F., Grešíková, M., Solgadi, A., Veksler, V., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001180 · Cited by 147 · see citing works

Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions

Osataphan, N., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15305 · Cited by 141 · see citing works

Sulforaphane protects the heart from doxorubicin-induced toxicity

Singh, P., Sharma, R., McElhanon, K. E., Allen, C. D., Megyesi, J. K., Beneš, H., & Singh, S. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.028 · Cited by 129 · see citing works

Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model

Riba, Á., Deres, L., Sümegi, B., Tóth, K., Szabados, E., & Halmosi, R. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6819281 · Cited by 129 · see citing works

The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results

Gál, R., Deres, L., Tóth, K., Halmosi, R., & Habon, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810152 · Cited by 116 · see citing works

Potential of resveratrol in the treatment of heart failure

Raj, P., Louis, X. L., Thandapilly, S. J., Movahed, A., Zieroth, S. R., & Netticadan, T. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.12.011 · Cited by 109 · see citing works

Doxorubicin‐Induced Cardiomyopathy in Children

Mancilla, T. R., Iskra, B., & Aune, G. J. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180017 · Cited by 108 · see citing works

Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress

Marques‐Aleixo, I., Alves, E. S., Mariani, D., Rizo‐Roca, D., Padrão, A. I., Rocha‐Rodrigues, S., Viscor, G., Torrella, J. R., Ferreira, R. M., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.10.008 · Cited by 108 · see citing works

Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity

López-Lluch, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.005 · Cited by 103 · see citing works

Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism

Sung, M. M., Das, S. K., Levasseur, J., Byrne, N. J., Fung, D., Kim, T. T., Masson, G., Boisvenue, J., Soltys, C.-L., Oudit, G. Y., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001677 · Cited by 102 · see citing works

Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway

LOU, Y., WANG, Z., XU, Y., Zhou, P. H., Cao, J., Li, Y., Chen, Y., Sun, J., & Fu, L. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2291 · Cited by 96 · see citing works

Cardioprotective Potentials of Plant‐Derived Small Molecules against Doxorubicin Associated Cardiotoxicity

Ojha, S. K., Taee, H. A., Goyal, S. N., Mahajan, U. B., Patil, C. R., Arya, D. S., & Rajesh, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5724973 · Cited by 94 · see citing works

Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure

Sung, M. M. Y., Byrne, N. J., Robertson, I. M., Kim, T. T., Samokhvalov, V., Levasseur, J. L., Soltys, C.-L. M., Fung, D., Tyreman, N., Denou, E., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00455.2016 · Cited by 88 · see citing works

Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors

Kirkham, A. A., & Davis, M. K. (2015) · Journal of Oncology · doi:10.1155/2015/917606 · Cited by 77 · see citing works

Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins

Dolinsky, V. W., Cole, L., Sparagna, G. C., & Hatch, G. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.008 · Cited by 76 · see citing works

N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and cardiomyocyte apoptosis in heart failure

WU, X.-Y., Luo, A., ZHOU, Y.-R., & Ren, J.-H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2292 · Cited by 73 · see citing works

Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions

Chen, J. J., Wu, P.-T., Middlekauff, H. R., & Nguyen, K.-L. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00646.2016 · Cited by 71 · see citing works

Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity

Smuder, A. J. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00161.2019 · Cited by 69 · see citing works

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

Singh, M., Kadhim, M. M., Jalil, A. T., Oudah, S. K., Aminov, Z., Alsaikhan, F., Jawhar, Z. H., Ramírez‐Coronel, A. A., & Farhood, B. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02936-4 · Cited by 68 · see citing works

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction

Zhang, L., Chen, J., Yan, L., He, Q., Xie, H., & Chen, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.646240 · Cited by 66 · see citing works

Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere

Campelj, D. G., Goodman, C. A., & Rybalka, E. (2021) · Cancers · doi:10.3390/cancers13143615 · Cited by 67 · see citing works

Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling

Marques‐Aleixo, I., Alves, E. S., Torrella, J. R., Oliveira, P. J., Magalhães, J., & Ascensão, A. A. M. R. (2017) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9412-4 · Cited by 63 · see citing works

Therapeutic potential of resveratrol in heart failure

Sung, M. M. Y., & Dyck, J. R. B. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12839 · Cited by 62 · see citing works

Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure

Sung, M. M. Y., Byrne, N. J., Kim, T. T., Levasseur, J. L., Masson, G., Boisvenue, J., Febbraio, M., & Dyck, J. R. B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00626.2016 · Cited by 60 · see citing works

A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin‐Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti‐Inflammatory Activities

Hu, L., Lan, H., Li, X.-M., & Jin, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2951697 · Cited by 58 · see citing works

Exercise Training and Cardiovascular Health in Cancer Patients

Squires, R. W., Shultz, A. M., & Herrmann, J. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0681-2 · Cited by 59 · see citing works

Resveratrol reduces cardiac NLRP3‐inflammasome activation and systemic inflammation to lessen doxorubicin‐induced cardiotoxicity in juvenile mice

Maayah, Z. H., Alam, A. S., Takahara, S., Soni, S., Ferdaoussi, M., Matsumura, N., Zordoky, B. N. M., Eisenstat, D. D., & Dyck, J. R. B. (2021) · FEBS Letters · doi:10.1002/1873-3468.14091 · Cited by 58 · see citing works

Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures

Yu, A. F., & Jones, L. W. (2016) · Cardio-Oncology · doi:10.1186/s40959-016-0011-5 · Cited by 56 · see citing works

Mitochondrial dysfunction in metabolism and ageing: shared mechanisms and outcomes?

López‐Lluch, G., Hernández‐Camacho, J. D., Fernández‐Ayala, D. J. M., & Navas, P. (2018) · Biogerontology · doi:10.1007/s10522-018-9768-2 · Cited by 57 · see citing works

Cancer therapy-induced autonomic dysfunction in early breast cancer: Implications for aerobic exercise training

Scott, J. M., Jones, L. W., Hornsby, W., Koelwyn, G. J., Khouri, M. G., Joy, A. A., Douglas, P. S., & Gilchrist, S. C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.113 · Cited by 55 · see citing works

CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism

Maayah, Z. H., Althurwi, H. N., Abdelhamid, G., Lesyk, G. M., Jurasz, P., & El‐Kadi, A. O. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.016 · Cited by 53 · see citing works

Resveratrol and exercise

Baltacı, S. B., Moğulkoç, R., & Baltacı, A. K. (2016) · Biomedical Reports · doi:10.3892/br.2016.777 · Cited by 53 · see citing works

Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes

Matsumura, N., Zordoky, B. N. M., Robertson, I. M., Hamza, S. M., Parajuli, N., Soltys, C.-L. M., Beker, D. L., Grant, M. K. O., Razzoli, M., Bartolomucci, A., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy064 · Cited by 53 · see citing works

Fine wine or sour grapes? A systematic review and meta-analysis of the impact of red wine polyphenols on vascular health

Weaver, S. R., Rendeiro, C., McGettrick, H. M., Philp, A., & Lucas, S. J. E. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02247-8 · Cited by 56 · see citing works

Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience

Huffman, D. M., Justice, J. N., Stout, M. B., Kirkland, J. L., Barzilai, N., & Austad, S. N. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw106 · Cited by 52 · see citing works

Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy

Choksey, A., & Timm, K. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010441 · Cited by 74 · see citing works

Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.

Zhang, J., Cui, X., Yan, Y., Li, M., Yang, Y. J., Wang, J., & Zhang, J. (2016) · Europe PMC (PubMed Central) · Cited by 51 · see citing works

Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity

Wang, F., Iskra, B. S., Kleinerman, E. S., Alvarez‐Florez, C., Andrews, T. C., Shaw, A., Chandra, J., Schadler, K., & Aune, G. J. (2018) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001112 · Cited by 51 · see citing works

Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation

Yang, H.-L., Hsieh, P., Hung, C., Cheng, H.-C., Chou, W.-C., Chu, P., Chang, Y.-C., & Tsai, K. (2020) · Cancers · doi:10.3390/cancers12051102 · Cited by 50 · see citing works

Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review

Gál, R., Halmosi, R., Gallyas, F., Tschida, M., Mutirangura, P., Tóth, K., Alexy, T., & Czopf, L. (2023) · Biomedicines · doi:10.3390/biomedicines11112888 · Cited by 53 · see citing works

Efficacy of Physical Exercise to Offset Anthracycline‐Induced Cardiotoxicity: A Systematic Review and Meta‐Analysis of Clinical and Preclinical Studies

Naaktgeboren, W. R., Binyam, D., Stuiver, M. M., Aaronson, N. K., Teske, A. J., van Harten, W. H., Groen, W. G., & May, A. M. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021580 · Cited by 48 · see citing works

A systematic comparison of exercise training protocols on animal models of cardiovascular capacity

Feng, R., Wang, L., Li, Z., Yang, R., Yu, L., Sun, Y., Yu, Q., Ghartey‐Kwansah, G., Sun, Y., Wu, Y., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.001 · Cited by 49 · see citing works

Exercise as A Potential Therapeutic Target for Diabetic Cardiomyopathy: Insight into the Underlying Mechanisms

Seo, D. Y., Ko, J. R., Jang, J. E., Kim, T. N., Youm, J. B., Kwak, H., Bae, J. H., Kim, A. H., Ko, K. S., Rhee, B. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246284 · Cited by 46 · see citing works

Oncology and Cardiac Rehabilitation: An Underrated Relationship

Venturini, E., Iannuzzo, G., D’Andrea, A., Pacileo, M., Tarantini, L., Canale, M. L., Gentile, M., Vitale, G., Sarullo, F. M., Vastarella, R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061810 · Cited by 45 · see citing works

CYP1B1 as a therapeutic target in cardio-oncology

Carrera, A. N., Grant, M. K. O., & Zordoky, B. N. M. (2020) · Clinical Science · doi:10.1042/cs20200310 · Cited by 44 · see citing works

Resveratrol prevents pathological but not physiological cardiac hypertrophy

Dolinsky, V. W., Soltys, C.-L. M., Rogan, K. J., Chan, A. Y. M., Nagendran, J., Wang, S., & Dyck, J. R. B. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1220-8 · Cited by 43 · see citing works

The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy

Marques‐Aleixo, I., Alves, E. S., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.002 · Cited by 44 · see citing works

Resveratrol-Encapsulated Mitochondria-Targeting Liposome Enhances Mitochondrial Respiratory Capacity in Myocardial Cells

Tsujioka, T., Sasaki, D., Takeda, A., Harashima, H., & Yamada, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010112 · Cited by 42 · see citing works

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity

Chen, R., Niu, M., Hu, X., & He, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1241225 · Cited by 42 · see citing works

The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?

Penna, F., Ballarò, R., & Costelli, P. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8041 · Cited by 42 · see citing works

Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies

Ghignatti, P. V. D. C., Nogueira, L. J., Lehnen, A. M., & Leguisamo, N. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83877-8 · Cited by 41 · see citing works

Resveratrol stimulates mitochondrial fusion by a mechanism requiring mitofusin-2

Robb, E. L., Moradi, F., Maddalena, L. A., Valente, A. J. F., Fonseca, J., & Stuart, J. A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.102 · Cited by 41 · see citing works

Cardioprotective strategies against doxorubicin-induced cardiotoxicity: A review from standard therapies to emerging mitochondrial transplantation

Ito‐Hagiwara, K., Hagiwara, J., Endo, Y., Becker, L. B., & Hayashida, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118315 · Cited by 40 · see citing works

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology

Abdelgawad, I. Y., Grant, M. K. O., & Zordoky, B. N. M. (2019) · Nutrients · doi:10.3390/nu11030627 · Cited by 39 · see citing works

The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction

Dolinsky, V. W. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0316 · Cited by 37 · see citing works

Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy

Zarrabi, A., Bishayee, A., Mirzaei, S., Gholami, M. H., Zabolian, A., Saleki, H., Bagherian, M., Torabi, S. M., Sharifzadeh, S. O., Hushmandi, K., et al. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220415131344 · Cited by 34 · see citing works

Experimental Studies of the Molecular Pathways Regulated by Exercise and Resveratrol in Heart, Skeletal Muscle and the Vasculature

Dolinsky, V. W., & Dyck, J. R. B. (2014) · Molecules · doi:10.3390/molecules190914919 · Cited by 34 · see citing works

Bénéfices de l’activité physique pendant et après cancer : des connaissances scientifiques aux repères pratiques

Ancellin, R., & Saintignon, J. G.-D. (2017) · ONCOLOGIE · doi:10.1007/s10269-017-2703-3 · Cited by 32 · see citing works

Resveratrol reduces the apoptosis induced by cigarette smoke extract by upregulating MFN2

Song, C., Luo, B., & Gong, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175009 · Cited by 32 · see citing works

Antineoplastic copper coordinated complexes (Casiopeinas) uncouple oxidative phosphorylation and induce mitochondrial permeability transition in cardiac mitochondria and cardiomyocytes

Silva‐Platas, C., Guerrero-Beltrán, C. E., Carrancá, M., Castillo, E. C., Bernal‐Ramírez, J., Oropeza‐Almazán, Y., González, L. N., Rojo, R., Martínez, L. E., Valiente-Banuet, J. I., et al. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-015-9640-x · Cited by 32 · see citing works

Exercise Training in Cancer Control and Treatment

Christensen, J. F., Simonsen, C., & Højman, P. (2019) · Comprehensive physiology · doi:10.1002/j.2040-4603.2019.tb00064.x · Cited by 31 · see citing works

All‐trans retinoic acid protects against doxorubicin‐induced cardiotoxicity by activating the ERK2 signalling pathway

Yang, L., Luo, C. Y., Chen, C., Wang, X., Shi, W., & Liu, J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13377 · Cited by 30 · see citing works

Anticancer effects of resveratrol in canine hemangiosarcoma cell lines

Carlson, A., Alderete, K. S., Grant, M. K. O., Seelig, D. M., Sharkey, L. C., & Zordoky, B. N. M. (2017) · Veterinary and Comparative Oncology · doi:10.1111/vco.12375 · Cited by 30 · see citing works

Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy

Dozic, S., Howden, E. J., Bell, J. R., Mellor, K. M., Delbridge, L. M. D., & Weeks, K. L. (2023) · Cells · doi:10.3390/cells12091312 · Cited by 29 · see citing works

Aerobic Exercise Training as a Potential Cardioprotective Strategy to Attenuate Doxorubicin-Induced Cardiotoxicity

Kouzi, S. A., & Uddin, M. N. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3js5r · Cited by 29 · see citing works

HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner

Durham, K. K., Chathely, K. M., Mak, K. C., Momen, A., Thomas, C. T., Zhao, Y., MacDonald, M. E., Curtis, J. M., Husain, M., & Trigatti, B. L. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00521.2016 · Cited by 28 · see citing works

Exercise Training Preserves Myocardial Strain and Improves Exercise Tolerance in Doxorubicin-Induced Cardiotoxicity

Gomes-Santos, I. L., Jordão, C. P., Passos, C. S., Brum, P. C., de Oliveira, E. M., Chammas, R. J., Camargo, A. A., & Negrão, C. E. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.605993 · Cited by 28 · see citing works

Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy.

Gabani, M. H., Castañeda, D., Nguyen, Q. M., Choi, S. K., Chen, C., Mapara, A., Kassan, A., González, A. A., Khataei, T., Ait‐Aissa, K., et al. (2021) · Europe PMC (PubMed Central) · doi:10.7759/cureus.18194 · Cited by 28 · see citing works

The Role of Mitochondrial Quality Control in Anthracycline‐Induced Cardiotoxicity: From Bench to Bedside

Li, Y., Lin, R., Peng, X., Wang, X., Liu, X., Li, L., Bai, R., Wen, S., Ruan, Y., Chang, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3659278 · Cited by 28 · see citing works

Resveratrol combats chronic diseases through enhancing mitochondrial quality

Tao, W., Zhang, H., Jiang, X., & Chen, N. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250140 · Cited by 29 · see citing works

Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner

Durham, K. K., Kluck, G. E. G., Mak, K. C., Deng, Y. D., & Trigatti, B. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00432.2018 · Cited by 26 · see citing works

The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study

Rahmanifard, M., Vessal, M., Noorafshan, A., Karbalay‐Doust, S., & Naseh, M. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09685-8 · Cited by 25 · see citing works

The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure

Lindsey, M. L., Lange, R. A., Parsons, H. M., Andrews, T. C., & Aune, G. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00099.2014 · Cited by 25 · see citing works

Modulatory Effect of Aerobic Exercise Training on Doxorubicin-Induced Cardiotoxicity in Rats with Different Ages

Ahmadian, M., & Roshan, V. D. (2017) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9411-5 · Cited by 23 · see citing works

The interplay of exercise and polyphenols in cancer treatment: A focus on oxidative stress and antioxidant mechanisms

Wang, Y. (2024) · Phytotherapy Research · doi:10.1002/ptr.8215 · Cited by 23 · see citing works

Age-related effect of aerobic exercise training on antioxidant and oxidative markers in the liver challenged by doxorubicin in rats

Ahmadian, M., Roshan, V. D., & Leicht, A. S. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1470328 · Cited by 21 · see citing works

Exercise training improves heart rate recovery in women with breast cancer

Giallauria, F., Maresca, L., Vitelli, A., de Magistris, M. S., Chiodini, P., Mattiello, A., Gentile, M., Mancini, M. E., Grieco, A., Russo, A., et al. (2015) · SpringerPlus · doi:10.1186/s40064-015-1179-0 · Cited by 21 · see citing works

Protecting the heart in cancer therapy

Finet, J. E., & Tang, W. H. W. (2018) · F1000Research · doi:10.12688/f1000research.15190.1 · Cited by 20 · see citing works

Rat Model of Cardiotoxic Drug-Induced Cardiomyopathy

Nakahara, T., Tanimoto, T., Petrov, A. D., Ishikawa, K., Strausś, H. W., & Narula, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8597-5_17 · Cited by 19 · see citing works

Normal tissue and tumor microenvironment adaptations to aerobic exercise enhance doxorubicin anti-tumor efficacy and ameliorate its cardiotoxicity in retired breeder mice

Wakefield, Z. R., Tanaka, M., Pampo, C., Lepler, S. E., Rice, L. P., Guingab-Cagmat, J. D., Garrett, T. J., & Siemann, D. W. (2021) · Oncotarget · doi:10.18632/oncotarget.28057 · Cited by 18 · see citing works

EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol

Keats, M. R., Grandy, S. A., Giacomantonio, N., Macdonald, D. A., Rajda, M., & Younis, T. (2016) · Pilot and Feasibility Studies · doi:10.1186/s40814-016-0084-9 · Cited by 18 · see citing works

Doxorubicin‐Induced Cardiomyopathy in Children

Mancilla, T. R., Iskra, B. S., & Aune, G. J. (2019) · Comprehensive physiology · doi:10.1002/j.2040-4603.2019.tb00082.x · Cited by 16 · see citing works

A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy

Matsumura, N., Robertson, I. M., Hamza, S. M., Soltys, C.-L. M., Sung, M. M. Y., Masson, G., Beker, D. L., & Dyck, J. R. B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00604.2016 · Cited by 15 · see citing works

New insights into mitochondrial quality control in anthracycline-induced cardiotoxicity: molecular mechanisms, therapeutic targets, and natural products

Li, W., Zhang, Y., Yan, W., Ling, G., Zhang, Y., Li, Y., Guo, S., Tan, N., Ma, L., Li, W., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.103810 · Cited by 14 · see citing works

Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure

Grois, L., Hupf, J., Reinders, J., Schröder, J., Dietl, A., Schmid, P. M., Jungbauer, C. G., Resch, M., Maier, L. S., Luchner, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169743 · Cited by 14 · see citing works

Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome

Ho, W.-H. J., Marinova, M. B., Listijono, D. R., Bertoldo, M. J., Richani, D., Kim, L., Brown, A., Riepsamen, A. H., Cabot, S., Frost, E. R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00119-w · Cited by 13 · see citing works

Exercise, cancer and cardiovascular disease: what should clinicians advise?

Zimmerman, A., Planek, M. I. C., Chu, C., Oyenusi, O., Paner, A., Reding, K. W., Skeete, J., Clark, B., & Okwuosa, T. M. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000228 · Cited by 12 · see citing works

New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine

Kapturska, K., & Pawlak, A. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12917 · Cited by 9 · see citing works

Standard and New Echocardio Techniques, Such as Global Longitudinal Strain, to Monitor the Impact of Diets on Cardiovascular Diseases and Heart Function

Sartorio, A., Pont, C. D., & Romano, S. L. (2024) · Nutrients · doi:10.3390/nu16101471 · Cited by 9 · see citing works

Effect of Resveratrol Administration on the Element Metabolism in the Blood and Brain Tissues of Rats Subjected to Acute Swimming Exercise

Baltacı, A. K., Arslangil, D., Moğulkoç, R., & Patlar, S. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0792-2 · Cited by 9 · see citing works

Resistance training improves cardiac function and cardiovascular autonomic control in doxorubicin-induced cardiotoxicity

Feitosa, L. A. D. S., Carvalho, J. S., Dantas, C. O., Souza, D. S., de Vasconcelos, C. M. L., Miguel‐dos‐Santos, R., Lauton‐Santos, S., Quintans‐Júnior, L. J., dos Santos, M. R. V., Santana‐Filho, V. J., et al. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09627-w · Cited by 9 · see citing works

Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart

Chicco, A. J., Schneider, C. M., & Hayward, R. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00636.2004 · Cited by 120 · see citing works

Resistance Training Protects against Cardiac Damage in Doxorubicin-Induced Cardiotoxicity in Rats

Sequeira, C. M., Evangelista, J. F., Alves, R., Nascimento, A. L. R., & Matsuura, C. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003809 · Cited by 2 · see citing works

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer

Uurasmaa, T., Bourdin, P., Nammas, W., Latifi, S., Liljenbäck, H., Saraste, A., Eskola, O., Rajander, J., Roivainen, A., Rundqvist, H., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06108-y · Cited by 4 · see citing works

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

Tatlıdede, E., Şehırlı, Ö., Velioğlu‐Öğünç, A., Çetınel, Ş., Yeğen, B. Ç., Yarat, A., Süleymanoğlu, S., & Şener, G. (2009) · Free Radical Research · doi:10.1080/10715760802673008 · Cited by 156 · see citing works

Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer

Scott, J. M., Khakoo, A. Y., Mackey, J. R., Haykowsky, M. J., Douglas, P. S., & Jones, L. W. (2011) · Circulation · doi:10.1161/circulationaha.111.021774 · Cited by 188 · see citing works